IMS Health

Report: Total global spending on oncology medicines reached $100B in 2014

Wednesday, May 6, 2015 02:53 PM

Earlier diagnosis, longer treatment duration and increased effectiveness of drug therapies are contributing to rising levels of spending on medicines for cancer care, according to a new report released by the IMS Institute for Healthcare Informatics, a global information and technology services company based in Parsippany, N.J. The report stated total global spending on oncology medicines—including therapeutic treatments and supportive care—reached the $100 billion threshold in 2014, even as the share of total medicine spending of oncologics increased only modestly.

More... »

Quest Diagnostics

Study: 2014 a record-setting year for U.S. medicines

Wednesday, April 15, 2015 12:44 PM

Total spending on U.S. medicines increased 10.3% on a real per capita basis to $373.9 billion in 2014, with a record volume of 4.3 billion prescriptions filled. The year also marked the highest number of transformative medicines launched in more than a decade, according to a new report issued by the IMS Institute for Healthcare Informatics. IMS Health is a global information and technology services company based in Parsippany, N.J.

More... »


Malin to acquire Serenus Biotherapeutics

Wednesday, March 4, 2015 01:22 PM

Serenus Biotherapeutics, a San Francisco, Calif.-based specialty biopharmaceutical company, has secured investment of up to $43 million from Malin, an Ireland-based global life sciences company focused on healthcare.

More... »

Lycera names Paul Sekhri president and CEO

Thursday, February 5, 2015 12:58 PM

Lycera, a biopharmaceutical company developing breakthrough medicines to treat cancer and autoimmune disease, has named Paul Sekhri president, CEO and a member of the board of directors, effective immediately. Sekhri brings more than 25 years of operational experience in the life sciences industry, including business development and strategy, general management, drug development, and commercial strategy.  He succeeds Kathleen M. Metters, Ph.D., who currently serves as senior advisor to the company.

More... »

Study: global spending on medicines to increase 30% by 2018, to $1.3 trillion

Thursday, November 20, 2014 01:38 PM

More specialty drug innovation, greater patient access to medicines and reduced impact from patent expiries will be the primary drivers of an increase in global medicine spending of up to 30% by 2018.

More... »

Impax to acquire Tower Holdings and Lineage Therapeutics

Wednesday, October 15, 2014 06:00 PM

Hayward, Calif.-based Impax Laboratories will acquire Tower Holdings, including operating subsidiaries CorePharma, based in Middlesex, N.J., Amedra Pharmaceuticals, based in Horsham, Penn., and Lineage Therapeutics, also based in Horsham, for $700 million in cash, subject to certain customary purchase price adjustments.

More... »

IMS Health acquires Cegedim’s CRM and software developer unit

Thursday, June 26, 2014 12:45 PM

IMS Health, which in the last year has been actively making acquisitions leading up to its April IPO, has announced its intention to acquire Paris-based Cegedim’s information solutions and customer relationship management (CRM) business for approximately $520 million in cash.

More... »

IMS Health acquires Forcea

Thursday, May 8, 2014 01:14 PM

IMS Health, a global information and technology services company, has acquired Forcea, a Belgium-based provider of business intelligence applications and analytics for hospitals and life sciences organizations.

More... »

Report: Life Science IT solutions lowering pharma costs, improving patient outcomes

Thursday, March 13, 2014 12:08 PM

Life sciences companies are aggressively embracing new technology-driven approaches to commercialize their products and reduce operating costs, according to a new report issued by the IMS Institute for Healthcare Informatics, a global information and technology services company.

More... »

IMS Health files for IPO

Monday, January 6, 2014 03:02 PM

IMS Health, a global information and technology services company, has publicly filed a registration statement with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering of its common stock.

More... »


CWWeekly

May 26

inVentiv Health aims to help sponsors prepare for new E.U. regulations on observational studies

ACRP partners with CRO Analytics to measure investigative sites' views of clinical trial quality

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

May

Job satisfaction mixed as workload increases
Salaries not keeping pace with rise in work, responsibilities

Gamification moving from early science to patient use
Pharma looking to use games for early diagnosis, recruitment, adherence

Already a subscriber?
Log in to your digital subscription.

Purchase the May issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

April

PSI, INC Research, Chiltern best with sites
Strategic outsourcing prioritizing, improving site relationships

Regulatory compliance an increasing burden on sites
Increased staff time, materials, storage eroding site operating profit

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs